SILO PHARMA, INC. Crypto Asset Fair Value Current
SILO PHARMA, INC. (SILO) had Crypto Asset Fair Value Current of $205.41 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CryptoAssetFairValueCurrent · last filed 2026-08-13
- 2026-06-30: Crypto Asset Fair Value Current $205.41K.
- 2026-03-31: Crypto Asset Fair Value Current $173.46K.
- 2025-12-31: Crypto Asset Fair Value Current $221.82K.
- 2025-09-30: Crypto Asset Fair Value Current $72.28K.
| Period end | Crypto Asset Fair Value Current |
|---|---|
| 2026-06-30 | $205.41K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $173.46K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $221.82K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $72.28K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |